EZH2 and melanoma: MiR-137 regulates melanocyte differentiation by repressing MITF expression71 and exerts antitumor effects in melanoma cells by regulating MITF, c-MET, Y-box-binding protein 1, and enhancer of zeste homolog 2 (EZH2)72.